key: cord-0906827-3cipvyf4
authors: Alnashri, Huda; Aljohani, Naif; Tayeb, Sarah; Rabie, Nada; AlBenayan, Eyad; Alharthi, Adil; Samannodi, Mohammed
title: A Challenging Case of Multisystem Inflammatory Syndrome in Children Related to Coronavirus Disease-19 Hospitalized under Adult Medical Service
date: 2020-09-14
journal: IDCases
DOI: 10.1016/j.idcr.2020.e00957
sha: a50831add61960b0825f3a85113c190f3e966621
doc_id: 906827
cord_uid: 3cipvyf4

Data on multisystem inflammatory syndrome in children (MIS-C) related to coronavirus disease-19 (COVID-19) is increasing in the current COVID-19 pandemic. We present a 16 year old male who was hospitalized in July 2020 under adult medical service due to Kawasaki-like disease symptoms. Diagnosis of MIS-C related to COVID-19 was established by clinical features, elevated inflammatory markers, and positive SARS-COV 2 immunoglobulin G. We encourage all clinicians especially who practice adult medicine to be familiar with signs and symptoms of MIS-C to avoid delayed diagnosis and complications.

The novel coronavirus, which was temporarily named "2019 novel coronavirus (2019-nCoV)," emerged in Wuhan, China. As of February 24, 2020, 79331 confirmed cases, and 2618 deaths due to coronavirus disease-19 (COVID-19) have been reported worldwide [1] . The occurrence rate is relatively low in people 21 years old and younger [2, 3] . Recent reports from the North America and European countries on Kawasaki-like disease or multisystem inflammatory syndrome in children (MIS-C) possible association with COVID-19 [4] [5] [6] [7] . The majority of patients tested positive for SARS-CoV-2 infection by RT-PCR, antibody testing, or both, and had an epidemiologic link to a person with COVID-19 [7] . However, the presence of the specific SARS-CoV-2 antibody alone may not be sufficient to explain the causal relationship in which COVID-19 evokes an abnormal immunological response leading to MIS-C [6] . Researches had reported cases of an alarming apparent side effect of COVID-19 in children, sometimes between two and four weeks after the infection [7] . The majority of the children were previously healthy, 80% of the children who developed the condition required intensive care, 2% had died , many of the children developed cardiovascular ( kawasaki like ) and clotting problems and many had gastrointestinal symptoms. Patients may presented with a persistent fever and a constellation of symptoms including hypotension, multiorgan (e.g., cardiac, gastrointestinal, renal, hematologic, dermatologic and neurologic) involvement, and elevated inflammatory markers [5, 7] . As the literature on MIS-C related to COVID-19 is limited, we believe our case will increase the awareness of clinicians about MIS-C related to COVID-19 especially who practice adult medicine.

We present a 16 year old male who presented to hospital in July, 2020 with a 7 day history of fever, diarrhea, vomiting, and generalized abdominal pain. The symptoms were associated with bilateral knee joint pain, pleuritic chest pain for 5 days.

Four weeks ago, the patient and his parents had upper respiratory tract infection (URTI) like symptoms which were resolved completely within one week without seeking medical attention.

His physical exam at that time revealed blood pressure 102/60 mmHg, temperature 39.2 C, heart rate 98 beats/minute, respiratory rate 20 breath/minute, and oxygen saturation at 98% room air. Prior leaving the hospital, CBC, coagulation profile, d-dimer, CRP, ferritin and troponin level were normalized. Patient has continued to do well with no recurring symptoms.

Our case is one of the few survived cases of MIS-C related to COVID-19 in Saudi Arabia. Our case met the case definition of MIS-C (Age 0-19 years, persistent fever ≥ 3 days, multiorgan involvement, Kawasaki like symptoms, and elevated inflammatory markers) [8] . It is a disease of pediatrics age group which makes the diagnosis usually challenging for clinicians who practice adult medicine. It is usually made by clinical features along with positive RT-PCR, antibody testing, or both [7] . The diagnosis was challenging as our patient was hospitalized under adult medical care while he is still in pediatrics age group especially with twice negative nasopharyngeal SARS-COV2 PCR. Later, positive SARS-COV2 immunoglobulin G has helped us to confirm the diagnosis in our patient.

A new coronavirus associated with human respiratory disease in China

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

A Novel Coronavirus from Patients with Pneumonia in China

Kawasakilike multisystem inflammatory syndrome in children during the covid-19 pandemic

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study

Paediatric multisystem inflammatory syndrome temporally associated with SARSCoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents

World Health Organization. Multisystem inflammatory syndrome in children and adolescents with COVID-19